30
Participants
Start Date
May 14, 2025
Primary Completion Date
March 31, 2026
Study Completion Date
March 31, 2026
prabotulinumtoxinA-xvfs
Each participant will receive 60 units (U) of prabotulinumtoxinA-xvfs into each SCM for a total of 120 U. Participants will return in 2 weeks to determine if any touch-up injection is needed.
RECRUITING
The Spiegel Center, Newton
Lead Sponsor
Collaborators (1)
Evolus, Inc.
INDUSTRY
Boston Medical Center
OTHER